EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Exenatide"
Narrow search

Narrow search

Year of publication
Subject
All
Exenatide 2 diabetes mellitus 2 evidence based medicine 2 meta-analysis 2 Bibliometrics 1 Bibliometrie 1 Diabetes 1 Meta-Analyse 1 Meta-analysis 1
more ... less ...
Online availability
All
Free 2
Type of publication
All
Article 2
Type of publication (narrower categories)
All
Article 1 Article in journal 1 Aufsatz in Zeitschrift 1
Language
All
English 2
Author
All
Chen, Bao-Ju 2 Chuko, Ju 2 Hu, Kuang-Yu 2 Tung, Chi-Hua 2
Published in...
All
International Journal of Management, Economics and Social Sciences (IJMESS) 1 International journal of management, economics and social sciences : IJMESS 1
Source
All
ECONIS (ZBW) 1 EconStor 1
Showing 1 - 2 of 2
Cover Image
Efficacy and safety of exenatide versus insulin in type 2 diabetes mellitus: Systematic review and meta-analysis
Chen, Bao-Ju; Chuko, Ju; Tung, Chi-Hua; Hu, Kuang-Yu - In: International Journal of Management, Economics and … 8 (2019) 3, pp. 253-265
Exenatide is one of a new class of medications (incretin mimetics) for the treatment of type 2 diabetes mellitus and … exenatide therapy compared to both placebo and insulin therapy in terms of main efficacy parameters and safety. We searched … June 2003 to July 2010. Exenatide reduced the mean differences of HbA1c comparing with both placebo (-0.88% [95% CI -0 …
Persistent link: https://www.econbiz.de/10012116460
Saved in:
Cover Image
Efficacy and Safety of Exenatide versus Insulin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
Chen, Bao-Ju; Chuko, Ju; Tung, Chi-Hua; Hu, Kuang-Yu - In: International journal of management, economics and … 8 (2019) 3, pp. 253-265
Exenatide is one of a new class of medications (incretin mimetics) for the treatment of type 2 diabetes mellitus and … exenatide therapy compared to both placebo and insulin therapy in terms of main efficacy parameters and safety. We searched … June 2003 to July 2010. Exenatide reduced the mean differences of HbA1c comparing with both placebo (-0.88% [95% CI -0 …
Persistent link: https://www.econbiz.de/10012115975
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...